78 related articles for article (PubMed ID: 1238186)
1. [Clinical experience with a new adrenal scanning agent, 6 beta-iodomethyl-19-nor-cholest-5(10)-en-3 beta-01-131I(NCL-6-131I, Adsterol)].
Fukuchi S; Nakajima Y; Miura T; Haruyama K; Nakamura M
Horumon To Rinsho; 1975 Oct; 23(10):1051-6. PubMed ID: 1238186
[No Abstract] [Full Text] [Related]
2. A new and superior adrenal scanning agent, NP-59.
Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
[No Abstract] [Full Text] [Related]
4. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
[No Abstract] [Full Text] [Related]
5. New adrenal-scanning agent.
Kojima M; Maeda M; Ogawa H; Nitta K; Ito T
J Nucl Med; 1975 Jul; 16(7):666-8. PubMed ID: 1151488
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
[No Abstract] [Full Text] [Related]
8. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
Ito T; Ogawa H; Maeda M; Kojima M
Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551
[No Abstract] [Full Text] [Related]
9. Tissue distribution studies in rats with two 131I-labeled adrenal scanning agents. Comparison between 131I-6-iodomethyl-19-norsitost-5(10)-en-3 beta-ol (NST-6-131I) and 19-iodositost-5-en-3 beta-ol (ST-19-131I).
Ito T; Yamauchi S; Maeda M; Komatsu H; Kojima M
Int J Nucl Med Biol; 1979; 6(3):163-6. PubMed ID: 521221
[No Abstract] [Full Text] [Related]
10. Adrenal scintigraphy with 131-I-adosterol.
Kasperlik-Zaluska A; Chomicki OA; Hartwig W; Mikolajków A; Siwicki H
Nuklearmedizin; 1976 Dec; 15(6):297-9. PubMed ID: 1012926
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic detection of hepatic metastases with 131I-labeled steroid in recurrent adrenal carcinoma: case report.
Watanabe K; Kamoi I; Nakayama C; Koga I; Matsuura K
J Nucl Med; 1976 Oct; 17(10):904-6. PubMed ID: 966060
[TBL] [Abstract][Full Text] [Related]
12. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
Ryo UY; Johnston AS; Kim I; Pinsky SM
Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
[TBL] [Abstract][Full Text] [Related]
13. Adrenal scintigraphy using 123I labeled 6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-123I).
Kamoi I; Oshiumi Y; Tateno Y; Shishido F; Ido T; Suzuki K; Irie T; Fukushi K; Nakayama C; Matsuura K; Itoh T; Ogawa H; Maeda M; Kojima M
Kaku Igaku; 1980 May; 17(4):389-93. PubMed ID: 7401398
[No Abstract] [Full Text] [Related]
14. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. II. Analysis of abnormal adrenal images.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Feb; 42(2):160-87. PubMed ID: 7110924
[No Abstract] [Full Text] [Related]
15. Chemical and radiochemical stability of the adrenal-scanning agents, 6beta-iodomethyl-19-norcholest-5(10-en-3beta-ol and 19-iodocholest-5-en-3beta-ol.
Scott KN; Mareci TH; Couch MW; Williams CM
Steroids; 1977 Oct; 30(4):511-9. PubMed ID: 605458
[TBL] [Abstract][Full Text] [Related]
16. Adrenal imaging with 131I-19-iodocholesterol following long-term alternate-day steroids.
Keogh B; Bakshi SP; Parthasarathy KL; Chu TM; Murphy GP
N Y State J Med; 1976 Jan; 76(1):35-8. PubMed ID: 1107892
[No Abstract] [Full Text] [Related]
17. 3-(125I) Iodo-5-cholestene: rationale for its development as a potential adrenal scanning agent.
Owoyale JA; Szinai SS
Acta Pharm Suec; 1981; 18(4):227-32. PubMed ID: 7315367
[No Abstract] [Full Text] [Related]
18. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228
[No Abstract] [Full Text] [Related]
19. NCL-6-124I: a PET agent for the adrenal.
Somawardhana CW; Amartey JK; Kojima M; Lambrecht RM
Int J Rad Appl Instrum A; 1990; 41(12):1223-4. PubMed ID: 1963422
[TBL] [Abstract][Full Text] [Related]
20. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
